ICMR sees potential in ‘immunity-booster’ BCG

New Delhi, October 29

Bacillus Calmette-Guerin (BCG), the 1921 anti-tuberculosis vaccine, could have potential utility in Covid-19 management as it enhances immunity among the elderly, a new research has found.

The study by the ICMR followed 86 healthy elderly individuals aged 60 to 80 years a month after BCG vaccination and found the jab enhanced all kinds of antibodies in the target group. A section of researchers cites BCG shots as a contributing factor for lower Covid mortality among Indians. — TNS

Be the first to comment on "ICMR sees potential in ‘immunity-booster’ BCG"

Leave a comment

Your email address will not be published.


%d bloggers like this: